<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antigen, Antibody and Complement - Medical Microbiology</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- KaTeX for Math rendering -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js" onload="renderMathInElement(document.body, {
        delimiters: [
            {left: '$$', right: '$$', display: true},
            {left: '$', right: '$', display: false}
        ]
    });"></script>
    
    <link rel="stylesheet" href="../styles/main.css">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                
                <!-- TOP NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-01-introduction.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="topic-03-specific-immune-response.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 40%;"></div>
                        </div>
                        <span class="progress-text">Topic 2 of 5</span>
                    </div>
                </nav>

                <header class="document-header">
                    <div class="header-badge">
                        <span>üß¨</span>
                        <span>Topic 02</span>
                    </div>
                    <h1 class="document-title">Antigen, Antibody and Complement</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Basic Immunology and Serodiagnosis</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>25 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    
                    <!-- Section 1: Antigen -->
                    <section class="content-section" id="antigen">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üéØ</span>
                                Antigen
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>An antigen is a substance which, when introduced into the body, stimulates the production of an antibody, and specifically reacts with it.</p>
                            
                            <p><strong>Antigenic determinant</strong> is the smallest unit of antigenicity in a molecule of antigen. An antigen may possess a number of determinant groups or combining sites, each stimulating the production of an antibody that can bind only at that site. The antigenic determinants can be peptide groups in proteins, or hexasaccharides in polysaccharides.</p>
                            
                            <p><strong>Haptens</strong> are low molecular weight antigens which cannot induce the formation of antibody by themselves, but can react specifically with the antibodies produced against them. Haptens become capable of producing antibodies when they are combined with larger 'carrier' molecules.</p>

                            <h3>Properties of Antigens</h3>
                            <p>The antigenicity of a substance depends on the following factors:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Molecular weight</strong> Substances with high molecular weight are generally more antigenic than those with a low molecular weight. Haptens can induce immune response only when they are adsorbed on high molecular weight carrier.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Chemical nature</strong> With some exceptions, proteins and polysaccharides are highly antigenic as compared to lipids and nucleic acids.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Foreignness</strong> Under normal conditions, the body does not produce antibodies against its own antigens. When this mechanism of recognising self antigens is impaired, it may result in autoimmune disease. The degree of foreignness also influences the antigenicity. Antigens from other individuals of the same species (e.g. man to man) are less antigenic than those from other species (e.g. sheep to man).</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Susceptibility to tissue enzymes</strong> When introduced into the body, antigens are degraded by tissue enzymes to expose their antigenic determinants. Therefore, inert substances which are not affected by enzymes are not antigenic e.g. polystyrene latex particles.</span>
                                </li>
                            </ol>
                        </div>
                    </section>

                    <!-- Section 2: Antigenic Specificity -->
                    <section class="content-section" id="antigenic-specificity">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üîç</span>
                                Antigenic Specificity
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Antigenic specificity is not absolute. Cross reactions can occur between an antigen with an antibody stimulated by another related antigen. This may occur due to sharing of similar antigenic determinants by different antigens (Fig.2.1).</p>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-c4ecb51b.jpeg" alt="The interaction between an antigenic (Ag) determinant and antibody (Ab) combining sites of various specificities" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.1 The interaction between an antigenic (Ag) determinant and antibody (Ab) combining sites of various specificities</figcaption>
                            </figure>

                            <p>Based on their specificity, natural tissue antigens can be of various types:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Autoantigens</strong> Autoantigens are self-antigens which are ordinarily non-antigenic, because the body recognises self-antigens. However, those antigens which are not found in free circulation or in tissue fluids (e.g. lens protein of the eye); or the antigens which are not present during the embryonic life, but develop later (e.g. sperm cells), are not recognised as self-antigens. Antibodies are produced against these antigens when they come into circulation accidentally. In autoimmune diseases, the body for one reason or another, fails to recognise autoantigens.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Isoantigens</strong> These are inherited antigens found in some, but not in all members of a species. Members of a species can be grouped depending upon the presence of different isoantigens. For example, blood group antigens (A and B) and human leucocyte antigens.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Species specific antigens</strong> All members of a species have a common antigen on their tissue cells. Members of related species may have some similarities in their antigens which may lead to cross reactions. This specificity is useful in establishing evolutionary relationships among various species.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Organ specific antigens</strong> These antigens are found in the same organ of different species. For example, antirabies vaccine prepared in sheep brain tissue may lead to neurological paralysis when introduced into a human body, due to sharing of the same antigen by the human and sheep brain. Therefore, antibodies produced against sheep brain antigen may cross-react with human brain causing damage.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Heterophile antigens</strong> Some closely related antigens are found to be present in some bacteria, plants and animals. Some such antigens are used for the diagnosis of diseases such as typhus fever caused by rickettsiae (Weil-Felix test). This test uses antigens of some species of Proteus organisms which can react with antibodies produced by rickettsiae.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Microbial antigens</strong> Microorganisms including viruses, bacteria, fungi, protozoa and helminths contain a large number of antigenic substances, which, when introduced into a human body, stimulate immune response. These antigens may be a part of the physical structure of a microorganism, or it may be a chemical, produced or released as a result of metabolism. Detection of these antigens or their specific antibodies is an important tool for the diagnosis of infectious diseases.</span>
                                </li>
                            </ol>
                        </div>
                    </section>

                    <!-- Section 3: Antibody Structure -->
                    <section class="content-section" id="antibody">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõ°Ô∏è</span>
                                Antibody
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Antibody is an immunoglobulin which is produced in the body as a response to a stimulus by an antigen; and reacts specifically with it. Chemically, immunoglobulins are proteins and constitute 20-25 per cent of total serum proteins. The term 'immunoglobulin' is a chemical and structural concept whereas the term 'antibody' is a biological and functional concept. The body can produce various types of antibodies which can react specifically only with the antigens which caused their production.</p>

                            <h3>Structure of Immunoglobin</h3>
                            <p>All immunoglobulins have a similar basic structure. However, they can show a great diversity in the capacity to produce specific antigen combining sites. Each immunoglobulin (Ig) molecule consists of two unequal pairs of polypeptide chains held together by disulphide (-s-s-) bonds. The two short chains are called light chains (L) whereas the two long chains are called heavy chains (H). Each chain has a constant region called 'carboxy terminal' (C) and a variable region called 'amino terminal' (V) (Fig.2.2).</p>
                            <p>The domains at the amino terminal (V) are variable while those at the carboxy terminal (C) are constant. Each domain has a specific biological activity such as antigen binding, complement activation or monocyte binding (Fig. 2.3).</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-1a4efbf0.jpeg" alt="A schematic diagram of an immunoglobulin molecule" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.2 A schematic diagram of an immunoglobulin molecule</figcaption>
                            </figure>

                            <p>The H and L chains are folded in three dimensions by disulphide bonds to construct 'domains'.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-44f869fd.jpeg" alt="Immunoglobulin domains" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.3 Immunoglobulin domains</figcaption>
                            </figure>

                            <p><strong>Heavy (H) chains</strong> The long or heavy (H) chains are not identical in all immunoglobulins. Based on structural and antigenic differences in heavy chains, immunoglobulins are divided into five groups or subclasses. These are designated as IgG, IgM, IgA, IgD and IgE. The H-chain specificity of each of the above classes is symbolised as Œ≥ (gamma) for IgG, Œº (mu) for IgM, Œ± (alpha) for IgA, Œ¥ (delta) for IgD and Œµ (epsilon) for IgE.</p>
                            <p>The portion of the H-chain which is not involved in the antibody combining site i.e. Fc fragment of the constant region (see fragments of immunoglobulin below), carries the sites for various biological activities such as complement fixation, attachment to phagocytic cells, placental transfer, degranulation of mast cells and skin fixation.</p>

                            <p><strong>Light (L) chains</strong> The light chains do not vary according to the immunoglobulin subclass. They always belong to one of the two types, kappa (Œ∫) and lambda (Œª). Both may occur in all classes of immunoglobulins; but any one molecule contains either kappa or lambda chains, not both. The kappa and lambda chains occur in a ratio of 2:1 in human serum.</p>

                            <p><strong>Combining sites</strong> The antigen combining sites of each antibody molecule are located at the aminoterminal end within the variable regions of both heavy (V_H) and light (V_L) chains (Fig.2.3). This is the main biological activity of an antibody molecule. The specificity of an antibody is determined by the sequence of amino acids and its 3-dimensional configuration of domains achieved by disulphide bonds in this variable region. On the other hand, the constant region at the carboxyterminal has a constant or non-variable sequence of amino acids in the H chain, and, either kappa or lambda sequence on the L chain. In the L chain, the constant and variable regions are of equal length, whereas in the H chain the variable region constitutes about one-fifth of the chain. The constant region on the L-chain is called C_L; and that on the heavy chains is called C_H. The C_H region is further divided into three to four regions (C_H1, C_H2, etc.). Differences in the constant regions of H chains have been used to divide immunoglobulins into classes and sub-classes.</p>

                            <h3>Fragments of Immunoglobulin</h3>
                            <p>Enzymes papain and pepsin are used to digest immunoglobulin molecules into discrete fragments.</p>
                            <p>Papain cleaves the antibody molecule just above the disulphide bonds which hold the two heavy chains together. This creates two identical Fab (fragment antigen binding) fragments, at the aminoterminal (Fig. 2.4). At the carboxy terminal, a fragment Fc (fragment crystallisable), which crystallises spontaneously at 4 ¬∞C, is formed. The Fc fragment is responsible for many biological functions of the immunoglobulin molecule, except antigen binding.</p>
                            <p>Pepsin cleaves the molecule just below the disulphide bonds connecting the two heavy chains (Fig. 2.4), which results in the production of one major fragment F(ab')_2, containing two antigen binding sites. The Fc portion is digested by pepsin into minor fragments.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-19830205.jpeg" alt="Fragments of immunoglobulin molecule after enzyme treatment" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.4 Fragments of immunoglobulin molecule after enzyme treatment</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 4: Immunoglobulin Classes -->
                    <section class="content-section" id="ig-classes">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üè∑Ô∏è</span>
                                Classes of Immunoglobulin
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>There are five major immunoglobulin classes, IgG, IgM, IgA, IgD and IgE. The structure and function of each is described below. Some of their characteristics are shown in Table 2.1.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-title">Table 2.1: Some characteristics of immunoglobulins</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table content-table--compact">
                                        <thead>
                                            <tr>
                                                <th>Characteristic</th>
                                                <th>IgG</th>
                                                <th>IgM</th>
                                                <th>IgA</th>
                                                <th>IgD</th>
                                                <th>IgE</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Sedimentation coefficient</td>
                                                <td>7S</td>
                                                <td>19S</td>
                                                <td>7S or 11S*</td>
                                                <td>7S</td>
                                                <td>8S</td>
                                            </tr>
                                            <tr>
                                                <td>Molecular weight</td>
                                                <td>150,000</td>
                                                <td>900,000</td>
                                                <td>170,000 or 400,000*</td>
                                                <td>180,000</td>
                                                <td>190,000</td>
                                            </tr>
                                            <tr>
                                                <td>Heavy chain symbol</td>
                                                <td>Œ≥</td>
                                                <td>Œº</td>
                                                <td>Œ±</td>
                                                <td>Œ¥</td>
                                                <td>Œµ</td>
                                            </tr>
                                            <tr>
                                                <td>Average concentration in normal serum (mg/dL)</td>
                                                <td>1000-1500</td>
                                                <td>60-180</td>
                                                <td>100-400</td>
                                                <td>3-5</td>
                                                <td>0.03</td>
                                            </tr>
                                            <tr>
                                                <td>Half-life in serum (days)</td>
                                                <td>23</td>
                                                <td>5</td>
                                                <td>6</td>
                                                <td>3</td>
                                                <td>2.5</td>
                                            </tr>
                                            <tr>
                                                <td>Prominent in external secretions</td>
                                                <td>-</td>
                                                <td>-</td>
                                                <td>++</td>
                                                <td>-</td>
                                                <td>+</td>
                                            </tr>
                                            <tr>
                                                <td>Crosses placenta</td>
                                                <td>+</td>
                                                <td>-</td>
                                                <td>-</td>
                                                <td>?</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Fixes complement</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>-</td>
                                                <td>-</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Examples of antibodies</td>
                                                <td>Many antibodies to toxins, bacteria, viruses, especially late in antibody response</td>
                                                <td>Many antibodies to infectious agents, especially early in antibody response; antipolysaccharide antibody; cold agglutinins</td>
                                                <td>Important as secretory antibody on mucous membranes</td>
                                                <td>No proven antibody activity; main immunoglobulin on surface of B lymphocytes in newborn</td>
                                                <td>Binds to mast and basophil cells, raised in allergic conditions and parasitic infections</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <p class="figure-caption" style="padding: var(--space-2); margin: 0;">*11S: molecular weight 400,000 IgA in external secretions; 7S: molecular weight 170,000 IgA in serum</p>
                            </div>

                            <h3>Immunoglobulin G (IgG)</h3>
                            <p>IgG is the predominant immunoglobulin in the adult, constituting about 75% of the total immunoglobulins in serum (8‚Äì16 mg/ml). It has a molecular weight of approximately 150,000 daltons and a sedimentation coefficient of 7 S.</p>
                            
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ÑπÔ∏è</span>
                                    <h4 class="callout-title">Note</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Sedimentation coefficient is the sedimentation rate in an ultracentrifuge, expressed in Svedberg units of time i.e. $10^{-13}$ seconds.</p>
                                </div>
                            </div>

                            <p>Each molecule of IgG consists of two L-chains and two H-chains of Œ≥-specificity, linked by 20‚Äì25 disulphide bonds. There is only one type of L-chain and one type of H-chain in each molecule.</p>
                            <p>There are four sub-classes of IgG (IgG1 to IgG4), each with a different type of gamma chain.</p>
                            
                            <p><strong>Functions of IgG</strong></p>
                            <p>While the antigen specificity of an IgG molecule lies within the Fab portion; the Fc portion is responsible for many biological activities:</p>
                            
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>1. Binding of complement</strong> Complement is a group of proteins present in the blood and other body fluids, which interacts with antigen-antibody complexes in a series of steps (Fig. 2.5A). In an antigen-antibody complex, the Fc portion of the IgG molecule combines with the complement to bring about destruction of the antigen.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>2. Opsonisation</strong> When IgG serves as a bridge between the antigen and the phagocytic cell, the phagocytic activity of the cell is enhanced. This is called opsonisation. This is achieved when the Fab portion of IgG binds to the antigen and Fc portion binds to the Fc receptor on the phagocytic cell (Fig. 2.5B).
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>3. Cellular cytotoxicity</strong> When the Fc portion of the IgG is attached to the Fc receptor on the phagocyte or natural killer (NK) cell, enzymes are released from the granules of these cells. These enzymes destroy the antigen (Fig. 2.5C).
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>4. Neutralization of toxins</strong> When a specific IgG antibody (anti-toxin) binds to a bacterial (toxin) antigen, it neutralises the toxic activity (Fig. 2.5D).
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>5. Crossing the placenta</strong> IgG is the only immunoglobulin which is capable of crossing the placenta. This helps in the transfer of passive immunity from the mother to the foetus. This immunity lasts for about six months after birth. The infant's own immune system begins to function by this time.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>6. Feedback suppression</strong> When IgG antibody specific for an antigen is passively administered into an individual, it suppresses the homologous antibody synthesis by a feedback process. This property of IgG is used for the suppression of anti-Rh (D) antibodies in an Rh-negative mother who has delivered an Rh-positive child. Synthesis of anti-Rh (D) antibodies is suppressed by passive administration of anti-Rh (D) IgG, immediately after delivery.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>7. Precipitation and agglutination</strong> IgG antibodies are capable of precipitating soluble antigens and agglutinating particulate antigens by forming lattice-like complexes, thus rendering the antigens inactive. IgG is more effective in tissue fluids.
                                    </span>
                                </li>
                            </ol>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-0d693f6c.jpeg" alt="Some function of IgG" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.5 Some function of IgG</figcaption>
                            </figure>

                            <h3>Immunoglobulin M (IgM)</h3>
                            <p>IgM is the largest of the immunoglobulins, with a molecular weight of about 900,000 to 1,000,000 (therefore called a 'millionaire molecule'). The sedimentation coefficient is 19S. It constitutes 5-10% of serum immunoglobulins (0.5 to 2 mg/ml).</p>
                            <p>IgM is a pentamer, made up of five basic subunits i.e. five units of two Œº-chains bound to two L-chains. These units are linked together by a protein called the 'J' or joining chain (Fig. 2.6a). The heavy chains are called Œº (mu) chains, and are longer than the Œ≥ (gamma) heavy chains of IgG, because they contain an additional domain, C_H4, located at the carboxyterminal of the H-chain. Since each IgM molecule has ten Fab segments, it can combine with up to ten antigenic sites. However, with antigens of a large size, this valency may fall to five, probably due to stearic hindrance.</p>
                            <p>IgM molecules are the earliest antibodies synthesised in response to antigenic stimulation. It is synthesised by the foetus from about 20 weeks of age. The presence of IgM antibodies in a foetus or a neonate indicates intrauterine infection because IgM cannot cross through the placenta. Congenital infections such as syphilis, rubella or toxoplasmosis can be diagnosed by detection of IgM antibodies in the newborn.</p>
                            <p>IgM antibodies are also the first to be produced in response to any antigenic stimulus, even in adult life. They are shortlived as compared to IgG. Therefore, their detection in the serum indicates a recent or current infection. IgM is selectively destroyed by 2-mercaptoethanol (O.12M), which does not affect IgG. This provides a simple method for estimating IgG and IgM separately.</p>
                            <p>There are two subclasses of IgM; IgM1 and IgM2.</p>
                            
                            <p><strong>Functions of IgM</strong></p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>1. Binding of complement</strong> IgM is the most efficient in performing this function among all the immunoglobulins due to its multiple Fc portion.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>2. Neutralization of toxins</strong> (Fig. 2.5D) This function also is similar to that of IgG.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>3. Agglutination</strong> IgM is much more efficient than other immunoglobulins in bringing about agglutination of particulate antigens such as those of bacteria, since it has ten functional antigen binding sites. Most of IgM (80%) is intravascular in distribution. Therefore it protects the blood stream against microbial invasion. IgM deficiency is often associated with septicaemias. It is present in the acute phase of infection.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>4. Opsonisation</strong> IgM is more effective in opsonisation than IgG.</span>
                                </li>
                            </ol>

                            <h3>Immunoglobulin A (IgA)</h3>
                            <p>IgA is the second most abundant class of immunoglobulins after IgG. It constitutes about 10% of total serum immunoglobulins (0.6 to 4.2 mg/ml).</p>
                            <p>IgA occurs in two forms. In the serum, it is present as a monomer i.e. one basic unit of two heavy chains bound to two light chains. The molecular weight of the monomer is about 170,000 daltons, with a sedimentation coefficient of 7 S. The heavy chains of IgA are called Œ± (alpha) chains (Fig. 2.6b). Unlike other immunoglobulins, the disulphide bonds in IgA link its light chains together, and not the heavy chains.</p>
                            <p>Besides occurring in the serum, IgA is a predominant immunoglobin in body's secretions such as saliva, tears, sweat and breast milk. The mucous membranes of respiratory, intestinal and genital tracts are also rich in IgA. In the body secretions, IgA occurs mainly as a dimer i.e. it has two basic subunits held together by the J-chain (Fig. 2.6b). The molecular weight of the dimer is about 400,000 daltons and has a sedimentation coefficient of 11 S. In addition, the dimer contains a protein known as the secretory or transport (T) piece. The T-piece is synthesised by the epithelial cells in the mucous membrane. The T-piece protects the IgA from the proteolytic enzymes and helps in its transport through the mucous membranes into the secretions.</p>
                            <p>There are two subclasses of IgA: IgA1 and IgA2.</p>
                            
                            <p><strong>Functions of IgA</strong></p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>1. Protection of body surfaces and mucous membranes</strong> Because it is predominant in body secretions, it protects the body against the entry of pathogens and from adherence to the mucous membranes. It forms an 'antibody paste' on the mucous surfaces which plays an important role in local immunity against respiratory and intestinal pathogens.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>2. Phagocytosis</strong> It promotes phagocytosis in the same way as the IgG and IgM.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>3. Passive immunity</strong> Ingestion of IgA in breast milk confers passive immunity from a mother to an infant. It does not cross through the placenta.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>4. Activation of complement</strong> Although it cannot fix complement, it can activate the alternate complement pathway.</span>
                                </li>
                            </ol>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-12da6f68.jpeg" alt="Structures of (A) IgM and (B) IgA molecules" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.6 Structures of (A) IgM and (B) IgA molecules</figcaption>
                            </figure>

                            <h3>Immunoglobulin D (IgD)</h3>
                            <p>Structurally, IgD resembles IgG. It exists as a monomer, with Œ¥(delta) heavy chains. It is mostly intravascular in distribution (3-5mg/100ml). Its concentration in serum is very low (0.03-0.05mg/ml).</p>
                            <p>Very little is known about the functions of IgD. It is active against antigens such as insulin, milk protein, nuclear and thyroid antigens, and penicillin. It is believed to be associated with lymphocyte activation and suppression.</p>
                            <p>There are two subclasses: IgD1 and IgD2.</p>

                            <h3>Immunoglobulin E (IgE)</h3>
                            <p>IgE exists as a monomer with Œµ (epsilon) heavy chains, has a molecular weight of about 200,000 daltons and sedimentation coefficient of 8S. It is present in very low concentration, about 0.02mg/ml. The Œµ chain contains an additional C‚ÇÅ‚ÇÅ‚ÇÑ domain in the constant region, similar to that of IgM. This C‚ÇÅ‚ÇÅ‚ÇÑ region is capable of binding to Fc receptors on mast cells and basophils. This interaction stimulates the development of Type I allergic reactions. IgE levels are also elevated in the serum of individuals with parasitic infections and may play a role in defence against parasites.</p>
                            <p>IgE is mostly extravascular in distribution. It does not fix complement or pass through the placenta.</p>
                        </div>
                    </section>

                    <!-- Section 5: Complement -->
                    <section class="content-section" id="complement">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß©</span>
                                Complement
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Complement is a complex system of proteins and other factors found in body fluids or on cell membranes of vertebrates. These components are capable of specific, sequential interactions leading to a number of physiological effects. Some of them have enzymatic activity, while others are activators or inhibitors of certain processes. Lysis of cells such as microorganisms or immunogenic red cells is the mainstay of this system. In addition, the complement system also plays a major role in the mediation of inflammation, in metabolism of immune complexes and in regulating the phagocytic activity.</p>
                            <p>At least 11 distinct components of human complement have been identified. Complement gets deteriorated very fast in vitro therefore it should either be used fresh or kept frozen. It can also be preserved by chemical methods such as Richardson method. Complement activity is destroyed by heating serum at 56¬∞C for 30 minutes, when it is said to be 'inactivated'.</p>
                            <p>Complement (C) is normally present in the body in an inactive form. When it is activated by antigen-antibody complexes, the components of C react in a specific sequence, which is called the complement cascade. Several biologically active fragments and components are released as byproducts during the reaction cascade. The preceding components act as enzymes on the succeeding components, cleaving them into unequal fragments. Generally, larger fragments join the cascade, smaller ones perform other biological functions.</p>

                            <h3>Activation of Complement</h3>
                            <p>There are two ways in which the complement can be activated; the classical pathway and the alternate pathway. Complement is activated by the classical pathway when an antigen-antibody complex initiate the reaction sequence by binding with the first component of C, namely C1. C1 exists in serum as a calcium ion ($Ca^{2+}$) dependant complex of three subunits, C1q, C1r and C1s.</p>

                            <h4>Classical pathway</h4>
                            <p>The sequence of the complement cascade by classical pathway can be summarised as follows:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        (i) Immunoglobulins IgG and IgM have receptors for C1q on their constant region of heavy chains, which are exposed when the immunoglobulin attaches to the specific antigen. In the presence of Ca++, C1q binds to the antigen-antibody (Ag-Ig) complex. C1q is sufficiently changed when it binds to the Ag-Ig complex to induce C1r, which in turn splits C1s resulting in the formation of Ag-Ig-C1qrs (Fig. 2.7).
                                        <div class="equation">
                                            $$Ag - Ig + C1q \xrightarrow{Ca^{2+}} Ag - IgC1q$$
                                            $$\xrightarrow{C1r + C1s} Ag - Ig - C1q \text{.r.s.}$$
                                        </div>
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        (ii) Activated C1 acquires esterase activity (C1s) and acts on C4, splitting it into C4a and C4b.
                                        <div class="equation">
                                            $$Cls + C4 \xrightarrow{C4a} C4b$$
                                        </div>
                                        C4a is released in the surrounding medium.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        (iii) C1s also cleaves C2 into two fragments, C2a and C2b
                                        <div class="equation">
                                            $$Cls + C2 \xrightarrow{C2b} C2a \xrightarrow{4b} C4b2a$$
                                        </div>
                                        (C3 convertase)<br>
                                        4b and 2a form a reversible complex. C4b2a which is known as C3 convertase. C2b is released.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        (iv) C4b2a (C3 convertase) rapidly activates and cleaves many molecules of C3 into C3a, C3b joins the cascade.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        (v) C5 convertase splits C5 into C5a, which is released into the environment. C5b initiates the formation of Terminal Complement Complex (TCC).
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        (vi) C6 and C7 are then added.
                                        <div class="equation">
                                            $$C5b + C6 \rightarrow C5b,6 + C7 \rightarrow C5b,6,7$$
                                        </div>
                                        C5b,6,7 is a heat stable trimolecular complex which binds to the cell membranes of target cells and prepares them for lysis by subsequent components C8 and C9. The unbound C5,6,7 complex has chemotactic and leucocyte activating properties.
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        (vii) Membrane bound C5b,6,7 constitutes receptor for C8 and allows its insertion into the target cell membrane.
                                        <div class="equation">
                                            $$C5b,6,7 + C8 \rightarrow C5b,6,7,8$$
                                        </div>
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        (viii) The C5b,6,7,8 complex forms small transmembrane channels in the target cell, and also facilitate polymerisation of C9 into an unfolding tubular structure. Poly C9. The polymerised C9 can insert into the cell membrane and form channels or holes into the target cell membrane. This disrupts the osmotic integrity of the membrane, followed by lysis of the cell. (Fig 2.7).
                                    </span>
                                </li>
                            </ol>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-350cc210.jpeg" alt="Activation sequence of the classical complement pathway" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.7 Activation sequence of the classical complement pathway</figcaption>
                            </figure>

                            <h4>The alternate pathway</h4>
                            <p>While the 'classical' pathway of complement activation starts by attachment of C1q to the antigen-antibody complex, an 'alternate' pathway exists which starts by activation of C3. In the classical pathway, C3 is activated by the C3 convertase (C4b2a). A variety of substances can bring about the formation of C3 activator that cleaves C3 in the similar way to that of C3 convertase in the classical pathway. This 'alternative pathway' then proceeds from C3 to C9, as in the classical pathway.</p>
                            <p>The alternate pathway of complement activation provides a natural defence mechanism against invasion by microorganisms, before the formation of antibodies. Activators of this pathway include</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(i) Lipopolysaccharides from gram negative bacteria.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(ii) Teichoic acid from the cell wall of gram positive bacteria.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(iii) Zymosan from the cell walls of fungi and yeast.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(iv) Some viruses and virus infected cells.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(v) Certain parasites such as trypanosomes.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(vi) Some tumour cells.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(vii) Therapeutic sulphydryl compounds.</span></li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 6: Biological Activities of Complement -->
                    <section class="content-section" id="biological-activities">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚öôÔ∏è</span>
                                Biological Activities of Complement
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Cytolysis</strong> Activation of complement results in cytolysis and bacteriolysis. Lysis of red cells coated with antigen by complement forms the basis of complement fixation test for the detection of either antigen or antibody.</p>
                            <p>Cytolysis may cause injury to normal tissues in allergic reactions or in autoimmune diseases.</p>
                            
                            <p><strong>Effects of C4a, C3a and C5a</strong> These smaller fragments are released in the environment during the formation of the complement cascade. Collectively, these fragments have effects on phagocytosis, anaphylaxis and inflammation. As anaphylotoxins they cause smooth muscle contraction, enhance mucus secretion, increase vascular permeability and induce release of histamine from basophils and mast cells.</p>
                            
                            <p><strong>Opsonization and Immune adherence</strong> The fragments C4b, C3b and iC3b (inactive 3b) promote adherence of antigen-antibody complexes to leucocytes or platelets, which can then be easily phagocytosed by macrophages. They also enhance phagocytosis of antibody-coated (opsonised) microorganisms by leucocytes and macrophages.</p>
                            
                            <p><strong>Hereditary deficiencies of C and Low serum C levels</strong> Deficiency or low level of complement may lead to increased susceptibility to infection and diseases like systemic lupus erythematosus (SLE) or acute glomerulonephritis.</p>
                        </div>
                    </section>

                </main>

                <!-- BOTTOM NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-01-introduction.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="topic-03-specific-immune-response.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 40%;"></div>
                        </div>
                        <span class="progress-text">Topic 2 of 5</span>
                    </div>
                </nav>

            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div id="lightbox" class="lightbox-modal" hidden aria-hidden="true" role="dialog" aria-label="Image viewer">
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>